Press Release   42% reduction in Scope 1 and 2 Greenhouse Gas emissions by 2030 (vs. 2022)25% reduction in Scope 3 GHG emissions by 2030 (vs. 2022) September 18, 2025 - EUROAPI’s near-term science-based emission reduction targets have been approved by the Science Based Targets initiative (SBTi1), confirming the company’s alignment with the Paris Agreement trajectory of limiting global warming to 1.5°C above pre-industrial levels. EUROAPI commits to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emiss ...

Core Viewpoint - The U.S. government, under President Trump, has directed the Environmental Protection Agency (EPA) to expedite the construction of facilities for the production of prescription drugs, active pharmaceutical ingredients, and other essential raw materials [1] Group 1 - The initiative aims to enhance domestic production capabilities for critical medical supplies [1] - This move is part of a broader strategy to reduce reliance on foreign sources for pharmaceuticals [1] - The focus on active pharmaceutical ingredients indicates a significant shift towards strengthening the U.S. pharmaceutical supply chain [1]